Introduction
In vitro release data of nanostructured materials compared to conventional drug-eluting systems have only scarcely been reported [1, 2] . Considering the in vitro release testing of e.g. drug-eluting stent systems reliable predictions are complicated due to many reasons including the small amount of drug loading within the coating, long periods of release and other factors such as very poor solubility of the used drug (power: 15%; speed: 10%.) using a CO2 laser plotter (Speedy 300, Trotec Leipzig, Germany) and JobControl software.
Surface characterization (SEM)
The morphology of the PLLA/SIR nonwoven structures was examined with a SEM QUANTA FEG 250 (FEI Company, Germany). The samples were fixed on aluminium trays and images were taken at various magnifications with prior sputter coating. Determination of fiber diameter was done at 3 different areas taking 10 fibers at each area into account.
Release setup and experimental design
In the first randomized release study we used 5 unsterilized laser-cut PLLA/SIR samples of all batches (NF 2A, NF 2B, NF 2C) without any treatment and 5 NH3-plama treated samples. The NH3-plasma process was performed via plasma etching (PE) for 1 minute and with 60% generator output. The radio frequency (RF) plasma generator (frequency 13.56MHz, power 100W, Diener electronic GmbH &Co. KG, Ebhausen, Germany) was operated at a low pressure of 0.3 mbar. As reference spray coated PLLA/SIR samples (n = 3) with an approximate layer thickness of 5 -10 µm and a surface of 60 mm² were used. This randomized study over 21 days has two objectives: firstly, to examine a hydrophilization of nonwoven matrices and secondly, the comparison of electrospun nanofibers and thin spray coated layers. Within a second controlled study two unsterilized lasercut samples (6 samples in sum) of each fiber diameter and layer thickness (batches NF 2A, NF 2B, NF 2C) were sorted and incubated for a long trial period of 58 d. Therefore, all nonwoven samples were characterized concerning their mass, layer thickness and surface structure ( Table 1) .
Due to insufficient stability of sirolimus a proven release medium was chosen consisting of 0.9% sodium chloride, 0.05% of a nonionic polyoxyethylene surfactant (Brij 35) and 0.0003% 3,5-di-tert-4-butylhydroxytoluene (BHT) dissolved in purified water [8] . The release conditions and media are equal for both studies. Each sample was positioned on a PTFE wire and stored in 2 mL of release medium (separate glass vial) on an agitated incubator at a shaking rate of 100 ± 5 rpm and 37 ± 2°C. The medium was changed and analyzed via HPLC at predefined time points (1 d, 2 d, 5 d, 9 d, 14 d, etc.), whereby the sample was dried briefly and transferred into fresh medium. Concerning SIR mass balance at the end of the study the samples were removed from the medium, dried briefly on a precision towel and transferred into a 4 mL glass vial for extraction, determining the remaining SIR content.
Sirolimus quantification
All samples containing sirolimus dissolved in the release medium were diluted with acetonitrile 1:1 (v/v). Quantification of SIR was performed using a high performance liquid chromatography (HPLC) system (Knauer GmbH, Germany) including degasser K-5004, pump K-1001, autosampler S3900, Jet stream oven and UV-detector K-2501. The used C18 column (YMC-Pack ODS-AQ, 120A, particle size 3 µm, 250 x 4.0 mm) was kept at a temperature of 50°C throughout the separation. Chromatography was performed under gradient conditions with a flow rate set to 1.0 mL/min and an injected sample volume of 30 µL. Detection was conducted at a wavelength of 270 nm. The system precision was 1.01% relative standard deviation. Results are presented as fractions (%) of the total drug load determined via summation of the amounts detected in the representative samples (media samples and the extracted residual content in the sample matrices).
Results and discussion

Surface morphology and thickness of nonwoven matrices
Different fiber diameters were produced via electrospinning and then examined within two release studies. Representative images of three different batches are shown in Figure 1 . It must, however, be critically stated that the fiber composition generally varies widely within a batch. Nevertheless, Table 1 . In a second study the nonwoven samples of all batches are assigned to different colored groups and plotted in Figure 3 A, B. 
Sirolimus release and residual loading
The results of the randomized first study of nonwoven matrices, whereby the layer thicknesses and fiber diameters were not considered are depicted in Figure 2 .
Here, the influence of entrapped air or a possible incomplete wetting of the hydrophobic nonwoven PLLA/SIR matrices were investigated by a comparison with hydrophilized samples via NH3-plasma treatment. An increase in burst release by hydrophilization could not be observed. Quite the contrary, the burst release was even reduced. Highly probable, this is because of SIR degradation during the plasma treatment in the first molecular layers, that are just a few nm thick, associated with a SIR loss of 3 -5%.
The total recovery of the drug using this release method is 74% (see Table 2 ) and comparable to spray coated layers. What has to be ascertained, therefore, is whether the loss of SIR amount is achieved either during the nonwoven production (electrospinning process) or owing to the poor stability in all water based release media for a prolonged period of time.
Additional issues were explored including the shelf life of the nonwovens at room temperature under dry storage conditions over 100 days. Even if it is hardly possible to achieve a comprehensive evaluation, it can already be mentioned that the SIR recovery within the nonwoven matrices is constant at 78 ± 2%. This suggests that at the beginning of the experiment, only approximately 80% of active ingredient SIR is incorporated (loading) and that this loss could not be detected within the release studies. The situation is quite different compared to conventional spray coatings, where 100% of SIR based on the quantity used can be retrieved by HPLC (data not shown). It can be reasonably assumed that the use of solvent mixtures or the electrospinning process intrinsically have an influence on the SIR amount in the nonwoven matrices. Therefore further investigations are required. In general the study design allows a SIR recovery of maximal 70 ± 5% over a period of 60 d regardless of nanostructured or thin film layers due to SIR degradation in all media examined so far. The mean drug recoveries for the samples of the different batches are summarized in Table 2 .
Results of the second study investigating SIR release from nonwovens with graded fiber strengths influencing the surface-to-volume ratio on (nano) molecular level are shown in Figure 3 . A slightly graduated initial release within a variety range of 10% is shown, but no trend depending on fiber diameter could be observed. However, concerning the whole layer thickness regardless of the fiber diameter in Figure 3 , B, a faster release with a larger thickness was identified after 10 days. Thereby, the thickness of group 4 and group 5 differs by a factor of 1.5. Compared to a thin spray-coated film (10 µm), the layer thickness is significant larger, however, the drug release lies in the same range. To provide final statements about nanostructured surface effects on drug release, higher differences in fiber diameter have to be produced. Within the fiber diameter range investigated here a reproducible release is feasible. 
Conclusion
A nanostructured drug delivery system for sirolimus was investigated and compared to thin spray-coated films. The nonwoven matrices were based on the encapsulation of sirolimus in the electrospun PLLA fibers. Surprisingly, the burst release of fibers was slower compared to films, even though they are produced using the same composition. The only difference was the solvent mixture and thereby the presence of TFE during electrospinning. In general, the fiber diameter and the layer thickness have only marginal effects on drug release within the range considered. In further studies potential differences in degree of crystallinity and degradation will be examined by DSC and GPC measurements. Similarly, the sterilization process for once sterilized samples (EO sterilization) has to be tested clarifying effects on the release kinetics. 
